tradingkey.logo

Champions Oncology Inc

CSBR
6.550USD
+0.020+0.31%
終値 02/06, 16:00ET15分遅れの株価
90.96M時価総額
36.04直近12ヶ月PER

Champions Oncology Inc

6.550
+0.020+0.31%

詳細情報 Champions Oncology Inc 企業名

Champions Oncology, Inc. is a preclinical and clinical research services provider. The Company is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions. This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. It also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.

Champions Oncology Incの企業情報

企業コードCSBR
会社名Champions Oncology Inc
上場日Nov 30, 1988
最高経営責任者「CEO」Brainin (Robert)
従業員数213
証券種類Ordinary Share
決算期末Nov 30
本社所在地One University Plaza,
都市HACKENSACK
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号07601
電話番号12018088400
ウェブサイトhttps://championsoncology.com
企業コードCSBR
上場日Nov 30, 1988
最高経営責任者「CEO」Brainin (Robert)

Champions Oncology Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Joel Ackerman
Mr. Joel Ackerman
Independent Director
Independent Director
1.06M
+94405.00%
Dr. Ronnie Morris, M.D.
Dr. Ronnie Morris, M.D.
Chairman of the Board
Chairman of the Board
858.88K
--
Dr. David Sidransky, M.D.
Dr. David Sidransky, M.D.
Independent Director
Independent Director
767.04K
--
Mr. Scott R. Tobin
Mr. Scott R. Tobin
Independent Director
Independent Director
53.40K
+23397.00%
Mr. Daniel N. (Dan) Mendelson
Mr. Daniel N. (Dan) Mendelson
Independent Director
Independent Director
--
--
Mr. David Miller, CPA
Mr. David Miller, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Philip Breitfeld, M.D.
Dr. Philip Breitfeld, M.D.
Independent Director
Independent Director
--
--
Mr. Robert (Rob) Brainin
Mr. Robert (Rob) Brainin
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Joel Ackerman
Mr. Joel Ackerman
Independent Director
Independent Director
1.06M
+94405.00%
Dr. Ronnie Morris, M.D.
Dr. Ronnie Morris, M.D.
Chairman of the Board
Chairman of the Board
858.88K
--
Dr. David Sidransky, M.D.
Dr. David Sidransky, M.D.
Independent Director
Independent Director
767.04K
--
Mr. Scott R. Tobin
Mr. Scott R. Tobin
Independent Director
Independent Director
53.40K
+23397.00%
Mr. Daniel N. (Dan) Mendelson
Mr. Daniel N. (Dan) Mendelson
Independent Director
Independent Director
--
--
Mr. David Miller, CPA
Mr. David Miller, CPA
Chief Financial Officer
Chief Financial Officer
--
--

収益内訳

FY2026Q2
FY2026Q1
FY2025
FY2025Q3
会社から関連データがまだ開示されていません。
地域別USD
会社名
収益
比率
United States
15.04M
0.00%
事業別
地域別
会社から関連データがまだ開示されていません。

株主

更新時刻: Sat, Nov 15
更新時刻: Sat, Nov 15
株主統計
種類
株主統計
株主統計
比率
Battery Management Corp
17.44%
New Enterprise Associates (NEA)
12.34%
Ackerman (Joel)
7.61%
West Elk Capital, LLC
6.36%
Morris (Ronnie)
6.19%
他の
50.07%
株主統計
株主統計
比率
Battery Management Corp
17.44%
New Enterprise Associates (NEA)
12.34%
Ackerman (Joel)
7.61%
West Elk Capital, LLC
6.36%
Morris (Ronnie)
6.19%
他の
50.07%
種類
株主統計
比率
Individual Investor
26.67%
Investment Advisor
23.00%
Venture Capital
12.34%
Hedge Fund
7.92%
Investment Advisor/Hedge Fund
3.88%
Research Firm
0.20%
他の
25.99%

機関投資家保有株

更新時刻: Mon, Dec 8
更新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
61
6.56M
52.08%
--
2025Q3
62
6.56M
52.44%
-79.02K
2025Q2
63
6.67M
52.80%
-161.89K
2025Q1
63
6.82M
51.27%
-269.97K
2024Q4
54
6.61M
53.30%
-64.85K
2024Q3
52
6.72M
54.61%
-200.66K
2024Q2
56
5.89M
46.40%
+140.55K
2024Q1
56
5.75M
45.40%
-421.54K
2023Q4
54
5.73M
45.75%
-128.46K
2023Q3
60
6.95M
52.42%
-72.37K
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
Battery Management Corp
2.42M
17.44%
+23.97K
+1.00%
Sep 30, 2025
New Enterprise Associates (NEA)
1.71M
12.34%
--
--
Sep 30, 2025
Ackerman (Joel)
1.06M
7.61%
+94.41K
+9.81%
Oct 30, 2025
West Elk Capital, LLC
882.58K
6.36%
-210.81K
-19.28%
Sep 30, 2024
Morris (Ronnie)
858.88K
6.19%
--
--
Aug 22, 2025
Sidransky (David)
767.04K
5.52%
--
--
Aug 22, 2025
Pessin (Norman H)
742.16K
5.34%
--
--
Aug 22, 2025
The Vanguard Group, Inc.
333.26K
2.4%
+6.23K
+1.90%
Sep 30, 2025
Tocqueville Asset Management LP
319.67K
2.3%
-80.21K
-20.06%
Sep 30, 2025
Mendelson (Daniel Newman)
198.63K
1.43%
--
--
Aug 22, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
iShares Micro-Cap ETF
0.01%
DFA Dimensional US Sustainability Core 1 ETF
0%
Dimensional US Core Equity 1 ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Micro-Cap ETF
比率0.01%
DFA Dimensional US Sustainability Core 1 ETF
比率0%
Dimensional US Core Equity 1 ETF
比率0%
iShares Core S&P Total U.S. Stock Market ETF
比率0%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
配当落ち日
種類
比率
データなし
日付
配当落ち日
種類
比率
データなし
KeyAI